JNCI:美国国家癌症年度报告:癌症死亡率持续下降,常见癌症5年存活率从50%上升到66%

2017-04-11 奇点糕 奇点网

3月31日,美国疾病控制与预防中心(CDC)、北美中央癌症登记协会(NAACCR)、美国癌症协会(ACS)和国家癌症研究所(NCI)联合在《Journal of the National Cancer Institute》杂志上发表了一份“美国国家癌症年度报告”(《Annual Report to the Nation on the Status of Cancer, 1975–2014, Fea

3月31日,美国疾病控制与预防中心(CDC)、北美中央癌症登记协会(NAACCR)、美国癌症协会(ACS)和国家癌症研究所(NCI)联合在《Journal of the National Cancer Institute》杂志上发表了一份“美国国家癌症年度报告”(《Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival》)。报告显示,美国癌症死亡率呈现持续下降趋势,大多数癌症的死亡率均有所下降。

报告收集了1975-2014年间的临床资料,作者指出,癌症死亡率的下降反映出预防工作方面的改善,包括对烟草贸易的控制,以及癌症的早期筛查,尤其是结直肠癌乳腺癌和子宫颈癌。除了预防,死亡率的降低当然还要依靠不断完善的各种癌症疗法的帮助。



男性的癌症发病率逐年降低,1999年-2008年以0.6%的比例降低,2008年-2013年以2.3%的比例降低;女性的癌症发病率在1999年-2013年没有发生明显的变化

报告显示,从2010年到2014年,男性每年的整体癌症死亡率下降了1.8%,在16种最常见的男性易患的癌症中,有11种死亡率下降。女性的死亡率相对男性下降的比例较低,为1.4%,其中18种最常见的癌症中有13种呈下降趋势。



男性的癌症死亡率在2000年-2014年,每年以1.8%的的比例下降;女性以1.4%的比例下降

除了成人,儿童每年的癌症死亡率同样有一定的下降,约为1.6%。报告中特别指出,肝癌在男性和女性中都呈上升趋势。除此之外,男性群体的胰腺癌和脑癌,女性子宫内膜癌的死亡率也有所升高。



1975年-1977年和2006年-2012年两个时间段,常见儿童肿瘤的5年存活率比较

据统计,在2009年到2013年,男性每年的癌症总体发病率下降了2.3%,但是报告同时指出,发病率可能会受到检测方法的影响。例如,新的前列腺癌的病例较同期减少,导致总发病率降低,这是由于前列腺特异性抗原检测应用的减少引起的。而在女性群体中,新发乳腺癌的比例有极小幅度的上升,这就可能使得女性的总体癌症发病率出现上升。

研究人员比较了1975-1977年和2006-2012年两个时间段中癌症患者的五年存活率,发现最常见癌症的5年存活率从50%上升到66%。乳腺癌患者的生存率从75%上升到91%,而肺癌的存活率从12%增加到19%,前列腺癌的存活率从68%增加到99%,结肠癌的存活率从50%增加到66%,膀胱癌的存活率从72%到79%。



1975年-1977年和2006年-2012年两个时间段,常见癌症类型的总体5年存活率比较,从表中可见,肺癌、食管癌、胰腺癌、肝癌这几种癌症虽然生存率有所提高,但仍然是“老大难”

不同种族和族裔群体的五年生存率差异依然存在。到2012年,白人所有癌症的总体五年生存率为67%,而非西班牙裔黑人患者为60%。与非西班牙裔白人患者相比,非西班牙裔黑人患者死亡风险高出33%,非西班牙裔美洲人/阿拉斯加本地人的死亡风险高出51%。

研究团队认为,按照现在精准医学和免疫治疗的发展速度,癌症的存活率(尤其是晚期癌症)还会进一步提升。但是现在面临的最大挑战,还是如何让更多的患者受惠于这些新疗法。

原始出处:

Jemal A, Ward E M, Johnson C J, et al. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival[J]. JNCI: Journal of the National Cancer Institute, 2017, 109(9).

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2045342, encodeId=1722204534229, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon May 08 00:22:00 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933725, encodeId=66031933e25e3, content=<a href='/topic/show?id=71a81258504' target=_blank style='color:#2F92EE;'>#NCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12585, encryptionId=71a81258504, topicName=NCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee7414, createdName=lanyan20020086, createdTime=Mon Sep 18 19:22:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862894, encodeId=59f61862894e4, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Mar 03 12:22:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186983, encodeId=f437186983aa, content=突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca432042642, createdName=lemon985, createdTime=Thu Apr 13 00:57:30 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473562, encodeId=edbf14e356232, content=<a href='/topic/show?id=0e3be140052' target=_blank style='color:#2F92EE;'>#癌症死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71400, encryptionId=0e3be140052, topicName=癌症死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eba97230640, createdName=wenjie, createdTime=Thu Apr 13 00:22:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186698, encodeId=78c018669811, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Apr 11 14:11:04 CST 2017, time=2017-04-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2045342, encodeId=1722204534229, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon May 08 00:22:00 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933725, encodeId=66031933e25e3, content=<a href='/topic/show?id=71a81258504' target=_blank style='color:#2F92EE;'>#NCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12585, encryptionId=71a81258504, topicName=NCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee7414, createdName=lanyan20020086, createdTime=Mon Sep 18 19:22:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862894, encodeId=59f61862894e4, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Mar 03 12:22:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186983, encodeId=f437186983aa, content=突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca432042642, createdName=lemon985, createdTime=Thu Apr 13 00:57:30 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473562, encodeId=edbf14e356232, content=<a href='/topic/show?id=0e3be140052' target=_blank style='color:#2F92EE;'>#癌症死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71400, encryptionId=0e3be140052, topicName=癌症死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eba97230640, createdName=wenjie, createdTime=Thu Apr 13 00:22:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186698, encodeId=78c018669811, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Apr 11 14:11:04 CST 2017, time=2017-04-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2045342, encodeId=1722204534229, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon May 08 00:22:00 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933725, encodeId=66031933e25e3, content=<a href='/topic/show?id=71a81258504' target=_blank style='color:#2F92EE;'>#NCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12585, encryptionId=71a81258504, topicName=NCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee7414, createdName=lanyan20020086, createdTime=Mon Sep 18 19:22:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862894, encodeId=59f61862894e4, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Mar 03 12:22:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186983, encodeId=f437186983aa, content=突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca432042642, createdName=lemon985, createdTime=Thu Apr 13 00:57:30 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473562, encodeId=edbf14e356232, content=<a href='/topic/show?id=0e3be140052' target=_blank style='color:#2F92EE;'>#癌症死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71400, encryptionId=0e3be140052, topicName=癌症死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eba97230640, createdName=wenjie, createdTime=Thu Apr 13 00:22:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186698, encodeId=78c018669811, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Apr 11 14:11:04 CST 2017, time=2017-04-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2045342, encodeId=1722204534229, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon May 08 00:22:00 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933725, encodeId=66031933e25e3, content=<a href='/topic/show?id=71a81258504' target=_blank style='color:#2F92EE;'>#NCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12585, encryptionId=71a81258504, topicName=NCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee7414, createdName=lanyan20020086, createdTime=Mon Sep 18 19:22:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862894, encodeId=59f61862894e4, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Mar 03 12:22:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186983, encodeId=f437186983aa, content=突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca432042642, createdName=lemon985, createdTime=Thu Apr 13 00:57:30 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473562, encodeId=edbf14e356232, content=<a href='/topic/show?id=0e3be140052' target=_blank style='color:#2F92EE;'>#癌症死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71400, encryptionId=0e3be140052, topicName=癌症死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eba97230640, createdName=wenjie, createdTime=Thu Apr 13 00:22:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186698, encodeId=78c018669811, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Apr 11 14:11:04 CST 2017, time=2017-04-11, status=1, ipAttribution=)]
    2017-04-13 lemon985

    突破

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2045342, encodeId=1722204534229, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon May 08 00:22:00 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933725, encodeId=66031933e25e3, content=<a href='/topic/show?id=71a81258504' target=_blank style='color:#2F92EE;'>#NCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12585, encryptionId=71a81258504, topicName=NCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee7414, createdName=lanyan20020086, createdTime=Mon Sep 18 19:22:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862894, encodeId=59f61862894e4, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Mar 03 12:22:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186983, encodeId=f437186983aa, content=突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca432042642, createdName=lemon985, createdTime=Thu Apr 13 00:57:30 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473562, encodeId=edbf14e356232, content=<a href='/topic/show?id=0e3be140052' target=_blank style='color:#2F92EE;'>#癌症死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71400, encryptionId=0e3be140052, topicName=癌症死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eba97230640, createdName=wenjie, createdTime=Thu Apr 13 00:22:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186698, encodeId=78c018669811, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Apr 11 14:11:04 CST 2017, time=2017-04-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2045342, encodeId=1722204534229, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon May 08 00:22:00 CST 2017, time=2017-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933725, encodeId=66031933e25e3, content=<a href='/topic/show?id=71a81258504' target=_blank style='color:#2F92EE;'>#NCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12585, encryptionId=71a81258504, topicName=NCI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ee7414, createdName=lanyan20020086, createdTime=Mon Sep 18 19:22:00 CST 2017, time=2017-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862894, encodeId=59f61862894e4, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sat Mar 03 12:22:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186983, encodeId=f437186983aa, content=突破, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca432042642, createdName=lemon985, createdTime=Thu Apr 13 00:57:30 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473562, encodeId=edbf14e356232, content=<a href='/topic/show?id=0e3be140052' target=_blank style='color:#2F92EE;'>#癌症死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71400, encryptionId=0e3be140052, topicName=癌症死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eba97230640, createdName=wenjie, createdTime=Thu Apr 13 00:22:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=186698, encodeId=78c018669811, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Apr 11 14:11:04 CST 2017, time=2017-04-11, status=1, ipAttribution=)]
    2017-04-11 doctorJiangchao

    继续学习。

    0

相关资讯

上千亿美元,70多种疗法!癌症治疗市场谁主沉浮?

过去五年开发的癌症治疗方法超过70种,这意味着全球需要更有效的癌症治疗方法。生物制药公司创新疗法的开发推动了整个癌症治疗市场的发展。根据QuintilesIMS的调查,2015年全球癌症治疗市场值为1070亿美元,预计每年增长7.5%-10.5%,至2020年,整个市场值将达到1500亿美元。

Cancer Cell:高剂量维生素C治疗癌症通过1期临床试验检测

最近一项临床试验发现向脑癌和肺癌病人体内常规注入日均推荐维生素C含量的800~1000倍是具有安全性的,该治疗方法或可提高标准癌症治疗的治疗结果。在这项发表在国际学术期刊Cancer Cell上的新研究中,爱荷华大学的研究人员还发现了改变癌细胞铁代谢的信号途径,这可导致癌细胞对高剂量维生素C诱导细胞死亡的敏感性增加。"这篇文章揭示了癌细胞的一

Lancet:全球十分之一的死亡与吸烟有关

尽管人人知晓吸烟有害健康,但全球总吸烟人数却一年比一年多。柳叶刀的最新调查发现,2015年,全球每天有10亿人在吸烟,全球十分之一的死亡是由吸烟引起,而在这些死亡人数中,有一半以上来自中国、印度、美国以及俄罗斯。本周,柳叶刀的一项新调查显示,全球十分之一的死亡是由吸烟引起,而在这些死亡案例中,一半以上发生在中国、印度、美国以及俄罗斯。这项研究整合了1990年至2015年间195个国家和地区的数据源

美国HIV相关癌症正在逐年减少

【艾滋病感染者的患癌档案正在改变】随着医学技术的不断发展,HIV不再是凶恶的杀手,它慢慢成为了一种慢性疾病。来自杜克大学的研究人员表示,这一转变过程HIV感染者的患癌情况提供了一个镜面影像。到2030年,HIV感染者中患癌的比例将呈戏剧性的趋势,由于自身免疫系统损坏而导致的癌症病例逐年减少。前列腺癌、肺癌和肝癌预计将成为这个群体中最常见的癌症,紧随其后的是肛门癌,肛门癌是通过人类乳头状瘤病毒(HP

《纽约客》深度长文:当人工智能遇上医生

说到悉达多•穆克吉博士,也许不少人对他的名字感到陌生。但不少人都熟知他的两部作品《众病之王:癌症传》和《基因:亲密的历史》。前者让穆克吉博士拿到了非小说类普利策奖,而后者则被比尔·盖茨先生推荐为2016年最佳书籍。最近,穆克吉博士在《纽约客》(The New Yorker)上刊发长文,以一名医生的独特视角,审视最近几年为医学带来冲击的人工智能。他在这篇长文中记录下的七段小故事,勾勒出了未来医生与人

抗癌物质萝卜硫素益处多多!盘点其功能研究进展

2017年3月13日/生物谷BIOON/---萝卜硫素(Sulforaphane),化学名为1-异硫氰酸-4-甲磺酰基丁烷,又称“莱菔硫烷” ,在西兰花、卷心菜、羽毛甘蓝、球芽甘蓝、芥蓝、北方圆红萝卜等十字花科植物中含量较丰富,是一种常见的抗氧化剂,是蔬菜中所发现的抗癌效果最好的植物活性物质,也是所有天然抗癌物质里,效力最强、效果最好的活性成分。 萝卜硫素结构式 1992年,美国